In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface

34Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hepatitis C virus (HCV) entry is dependent on host cell molecules tetraspanin CD81, scavenger receptor BI and tight junction proteins claudin-1 and occludin. We previously reported a role for CD81/claudin-1 receptor complexes in HCV entry; however, the molecular mechanism(s) driving association between the receptors is unknown. We explored the molecular interface between CD81 and claudin-1 using a combination of bioinformatic sequence-based modelling, site-directed mutagenesis and Fluorescent Resonance Energy Transfer (FRET) imaging methodologies. Structural modelling predicts the first extracellular loop of claudin-1 to have a flexible beta conformation and identifies a motif between amino acids 62-66 that interacts with CD81 residues T149, E152 and T153. FRET studies confirm a role for these CD81 residues in claudin-1 association and HCV infection. Importantly, mutation of these CD81 residues has minimal impact on protein conformation or HCVglycoprotein binding, highlighting a new functional domain of CD81 that is essential for virus entry. © 2012 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Davis, C., Harris, H. J., Hu, K., Drummer, H. E., Mckeating, J. A., Mullins, J. G. L., & Balfe, P. (2012). In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface. Cellular Microbiology, 14(12), 1892–1903. https://doi.org/10.1111/cmi.12008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free